AstraZeneca (Canada)
In research, AstraZeneca (Canada) stands highest in Medicine (#12,688 of 17,978 worldwide) and Health Sciences (#14,983 of 20,462 worldwide), over all time.
- World rank, all time
- #20,480 of 42,892
- Rank in Canada
- #433 of 896
- Research works
- 262 ▲ 124% vs 2013–17
- Citations
- 9k 34.3 per fractional work
- Top-10% rate
- 11.2% record average 16.5%
- Open access
- 44% world 28%
What is AstraZeneca (Canada) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #12,688 of 17,978 | 21.0% | 140 | |
| Health SciencesDomain | #14,983 of 20,462 | 21.0% | 148 |
Each strip is that field’s whole ranked pool, with the notch where AstraZeneca (Canada) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.7×. Every wedge is a field page.
- Medicine 3.7×
- Economics, Econometrics and Finance 3.6×
- Immunology and Microbiology 1.9×
- Mathematics 1.9×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Health Professions 1.0×
- Pharmacology, Toxicology and Pharmaceutics 1.0×
- Materials Science 0.6×
- Psychology 0.3×
- Decision Sciences 0.2×
- Neuroscience 0.1×
- Business, Management and Accounting 0.1×
- Social Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Chemistry 0.0×
- Engineering 0.0×
- Physics and Astronomy 0.0×
Who are the top researchers at AstraZeneca (Canada)?
Ranked on the composite score, Daniel Grima lead among researchers whose main affiliation is AstraZeneca (Canada).
- 1 Daniel Grima Canada · #1,574,716 worldwide 3 citations · 17 works
Which keywords describe research at AstraZeneca (Canada)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Prognostic Factors, Targeted Therapy, Chemotherapy, Rituximab, Epidemiology, Treatment and Genomic Profiling.
- Health Utility Measures
- Clinical Characteristics
- SARS-CoV-2
- ACE2 Receptor
- Respiratory
- Metastasis
- Radiotherapy
- Immunotherapy
- Eosinophils
- Clinical Practice Guidelines
- Allergic Diseases
- Treatment Guidelines
- ALK Inhibitors
- Chronic Lymphocytic Leukemia
- Quality of Life
- Genomic Profiling
- Inflammation
- Treatment
- Targeted Therapy
- Clinical Trials
- Epidemiology
- Prognostic Factors
- Chemotherapy
- Rituximab
- Diagnosis
- Management
- Biomarkers
- Genomic Aberrations
- EGFR Mutations
- Breast Cancer
- Asthma
- Cost of Care
- Financial Toxicity
- Metastatic Breast Cancer
- Global Burden
- COPD
- spirometry
- Neoadjuvant Therapy
- PET Imaging
- Cost-effectiveness Analysis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology6▲ 2.9×21 topics
- Clinical Trials5▲ 16×8 topics
- Prognostic Factors5▲ 24×8 topics
- Targeted Therapy5▲ 43×4 topics
- Chemotherapy4▲ 12×13 topics
- Treatment4▲ 6.1×12 topics
- Rituximab4▲ 46×3 topics
- Inflammation3▲ 3.0×13 topics
- Diagnosis3▲ 6.4×10 topics
- Genomic Profiling3▲ 58×2 topics
- Management3▲ 7.3×7 topics
- Quality of Life3▲ 4.1×9 topics
- Biomarkers3▲ 7.9×5 topics
- Chronic Lymphocytic Leukemia3▲ 121×1 topic
- Genomic Aberrations3▲ 121×1 topic
- ALK Inhibitors3▲ 83×1 topic
- EGFR Mutations3▲ 83×1 topic
- Treatment Guidelines3▲ 24×2 topics
- Breast Cancer2▲ 21×4 topics
- Allergic Diseases2▲ 74×1 topic
- Asthma2▲ 45×2 topics
- Clinical Practice Guidelines2▲ 8.2×7 topics
- Cost of Care2▲ 146×1 topic
- Eosinophils2▲ 74×1 topic
- Financial Toxicity2▲ 146×1 topic
- Immunotherapy2▲ 6.3×9 topics
- Metastatic Breast Cancer2▲ 78×2 topics
- Radiotherapy2▲ 10×4 topics
- Global Burden2▲ 6.9×3 topics
- Metastasis2▲ 10×5 topics
- COPD2▲ 51×1 topic
- Respiratory2▲ 35×2 topics
- spirometry2▲ 51×1 topic
- ACE2 Receptor2▲ 12×2 topics
- Neoadjuvant Therapy2▲ 12×4 topics
- SARS-CoV-22▲ 9.2×2 topics
- PET Imaging1▲ 16×4 topics
- Clinical Characteristics1▲ 20×2 topics
- Cost-effectiveness Analysis1▲ 32×1 topic
- Health Utility Measures1▲ 32×1 topic
Which research topics does AstraZeneca (Canada) publish most on?
By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations, Asthma and respiratory diseases and Economic and Financial Impacts of Cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Lymphocytic Leukemia Research Genetics 3 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 3 Asthma and respiratory diseases Physiology 2 works
- 4 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
- 5 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 2 works
- 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 7 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 8 Lung Cancer Research Studies Oncology 1 works
- 9 Cancer Genomics and Diagnostics Cancer Research 1 works
- 10 Machine Learning in Materials Science Materials Chemistry 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has AstraZeneca (Canada)'s research output changed?
Output in 2018–2022 was 124% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mississauga
- Nortel (Canada)
- Kellogg's (Canada)
- Hatch (Canada)
- Smiths Detection (Canada)
- Intertek (Canada)
- Trillium Health Centre
- College of Family Physicians of Canada
- General Electric (Canada)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.